Alvotech appoints patrik ling as vp of investor relations scandinavia

Reykjavik,  iceland (august 20, 2025) — alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that patrik ling has joined the company as vp investor relations scandinavia, based in stockholm.
ALVO Ratings Summary
ALVO Quant Ranking